Current and future lymphatic imaging modalities for tumor staging

Ghulam Murtaza; Kuo Gao; Tiegang Liu; Imran Tariq; Ashif Sajjad; Muhammad Rouf Akram; Meiying Niu; Guokai Liu; Zahid Mehmood; Guihua Tian

doi:10.1155/2014/714674

Current and future lymphatic imaging modalities for tumor staging

Ghulam Murtaza^*
, Kuo Gao
, Tiegang Liu
, Imran Tariq
, Ashif Sajjad
, Muhammad Rouf Akram
, Meiying Niu
, Guokai Liu
, Zahid Mehmood
, Guihua Tian

^*此作品的通讯作者

COMSATS University Islamabad
Beijing University of Chinese Medicine
University of the Punjab
University of Balochistan
University of Sargodha

科研成果: 期刊稿件 › 文献综述 › 同行评审

3 引用（Scopus）

摘要

Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. Some newer modalities, which are under development, and their potential uses will also be discussed in this review.

源语言	英语
文章编号	714674
期刊	BioMed Research International
卷	2014
DOI	https://doi.org/10.1155/2014/714674
出版状态	已出版 - 2014
已对外发布	是

访问文件

10.1155/2014/714674

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{b7fba0c60354439180e67482804fd7b6,

title = "Current and future lymphatic imaging modalities for tumor staging",

abstract = "Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. Some newer modalities, which are under development, and their potential uses will also be discussed in this review.",

author = "Ghulam Murtaza and Kuo Gao and Tiegang Liu and Imran Tariq and Ashif Sajjad and Akram, \{Muhammad Rouf\} and Meiying Niu and Guokai Liu and Zahid Mehmood and Guihua Tian",

year = "2014",

doi = "10.1155/2014/714674",

language = "English",

volume = "2014",

journal = "BioMed Research International",

issn = "2314-6133",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Current and future lymphatic imaging modalities for tumor staging

AU - Murtaza, Ghulam

AU - Gao, Kuo

AU - Liu, Tiegang

AU - Tariq, Imran

AU - Sajjad, Ashif

AU - Akram, Muhammad Rouf

AU - Niu, Meiying

AU - Liu, Guokai

AU - Mehmood, Zahid

AU - Tian, Guihua

PY - 2014

Y1 - 2014

N2 - Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. Some newer modalities, which are under development, and their potential uses will also be discussed in this review.

AB - Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. Some newer modalities, which are under development, and their potential uses will also be discussed in this review.

UR - https://www.scopus.com/pages/publications/84897520954

U2 - 10.1155/2014/714674

DO - 10.1155/2014/714674

M3 - Review article

C2 - 24757671

AN - SCOPUS:84897520954

SN - 2314-6133

VL - 2014

JO - BioMed Research International

JF - BioMed Research International

M1 - 714674

ER -

Current and future lymphatic imaging modalities for tumor staging

摘要

访问文件

其它文件与链接

指纹

引用此